nodes	percent_of_prediction	percent_of_DWPC	metapath
Lidocaine—osteoarthritis—Methylprednisolone—psoriatic arthritis	0.31	0.5	CpDpCtD
Lidocaine—osteoarthritis—Prednisone—psoriatic arthritis	0.31	0.5	CpDpCtD
Lidocaine—CYP2A6—Prednisolone—psoriatic arthritis	0.0397	0.145	CbGbCtD
Lidocaine—CYP2A6—Dexamethasone—psoriatic arthritis	0.0234	0.0857	CbGbCtD
Lidocaine—ABCB1—Methylprednisolone—psoriatic arthritis	0.0206	0.0756	CbGbCtD
Lidocaine—CYP3A7—Dexamethasone—psoriatic arthritis	0.016	0.0586	CbGbCtD
Lidocaine—CYP3A7-CYP3A51P—Dexamethasone—psoriatic arthritis	0.016	0.0586	CbGbCtD
Lidocaine—CYP2B6—Dexamethasone—psoriatic arthritis	0.0152	0.0558	CbGbCtD
Lidocaine—ABCB1—Betamethasone—psoriatic arthritis	0.0134	0.0492	CbGbCtD
Lidocaine—ABCB1—Prednisolone—psoriatic arthritis	0.0132	0.0485	CbGbCtD
Lidocaine—ABCB1—Prednisone—psoriatic arthritis	0.0125	0.0458	CbGbCtD
Lidocaine—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0124	0.0453	CbGbCtD
Lidocaine—CYP3A5—Dexamethasone—psoriatic arthritis	0.012	0.0439	CbGbCtD
Lidocaine—CYP2C8—Dexamethasone—psoriatic arthritis	0.0115	0.0423	CbGbCtD
Lidocaine—CYP3A4—Triamcinolone—psoriatic arthritis	0.00937	0.0343	CbGbCtD
Lidocaine—CYP2C9—Dexamethasone—psoriatic arthritis	0.00804	0.0295	CbGbCtD
Lidocaine—CYP3A4—Betamethasone—psoriatic arthritis	0.00804	0.0295	CbGbCtD
Lidocaine—CYP3A4—Prednisolone—psoriatic arthritis	0.00793	0.0291	CbGbCtD
Lidocaine—ABCB1—Dexamethasone—psoriatic arthritis	0.00781	0.0286	CbGbCtD
Lidocaine—CYP3A4—Prednisone—psoriatic arthritis	0.00749	0.0274	CbGbCtD
Lidocaine—CYP2D6—Dexamethasone—psoriatic arthritis	0.00736	0.0269	CbGbCtD
Lidocaine—ABCB1—Methotrexate—psoriatic arthritis	0.00627	0.023	CbGbCtD
Lidocaine—CYP3A4—Dexamethasone—psoriatic arthritis	0.00468	0.0171	CbGbCtD
Lidocaine—Visual disturbance—Betamethasone—psoriatic arthritis	0.000277	0.00258	CcSEcCtD
Lidocaine—Cardiac arrest—Triamcinolone—psoriatic arthritis	0.000275	0.00256	CcSEcCtD
Lidocaine—Dermatitis bullous—Betamethasone—psoriatic arthritis	0.000274	0.00256	CcSEcCtD
Lidocaine—Dermatitis bullous—Dexamethasone—psoriatic arthritis	0.000274	0.00256	CcSEcCtD
Lidocaine—Cardiac arrest—Methylprednisolone—psoriatic arthritis	0.000274	0.00256	CcSEcCtD
Lidocaine—Anaphylactoid reaction—Dexamethasone—psoriatic arthritis	0.000271	0.00253	CcSEcCtD
Lidocaine—Anaphylactoid reaction—Betamethasone—psoriatic arthritis	0.000271	0.00253	CcSEcCtD
Lidocaine—Euphoric mood—Prednisone—psoriatic arthritis	0.00027	0.00252	CcSEcCtD
Lidocaine—Sweating increased—Prednisolone—psoriatic arthritis	0.000265	0.00247	CcSEcCtD
Lidocaine—Osteoarthritis—Betamethasone—psoriatic arthritis	0.000262	0.00245	CcSEcCtD
Lidocaine—Osteoarthritis—Dexamethasone—psoriatic arthritis	0.000262	0.00245	CcSEcCtD
Lidocaine—Psychotic disorder—Dexamethasone—psoriatic arthritis	0.000256	0.00239	CcSEcCtD
Lidocaine—Psychotic disorder—Betamethasone—psoriatic arthritis	0.000256	0.00239	CcSEcCtD
Lidocaine—Depressed level of consciousness—Methotrexate—psoriatic arthritis	0.000254	0.00237	CcSEcCtD
Lidocaine—Skin exfoliation—Methotrexate—psoriatic arthritis	0.000251	0.00234	CcSEcCtD
Lidocaine—Asthma—Triamcinolone—psoriatic arthritis	0.00025	0.00233	CcSEcCtD
Lidocaine—Cardiac arrest—Betamethasone—psoriatic arthritis	0.000249	0.00233	CcSEcCtD
Lidocaine—Cardiac arrest—Dexamethasone—psoriatic arthritis	0.000249	0.00233	CcSEcCtD
Lidocaine—Bronchospasm—Methylprednisolone—psoriatic arthritis	0.000245	0.00229	CcSEcCtD
Lidocaine—Sweating increased—Triamcinolone—psoriatic arthritis	0.000243	0.00227	CcSEcCtD
Lidocaine—Sweating increased—Methylprednisolone—psoriatic arthritis	0.000243	0.00227	CcSEcCtD
Lidocaine—Coma—Methotrexate—psoriatic arthritis	0.00024	0.00224	CcSEcCtD
Lidocaine—Neuropathy peripheral—Prednisolone—psoriatic arthritis	0.000237	0.00222	CcSEcCtD
Lidocaine—Osteoarthritis—Prednisone—psoriatic arthritis	0.000228	0.00213	CcSEcCtD
Lidocaine—Psychotic disorder—Prednisone—psoriatic arthritis	0.000223	0.00208	CcSEcCtD
Lidocaine—Bradycardia—Prednisolone—psoriatic arthritis	0.000221	0.00207	CcSEcCtD
Lidocaine—Sweating increased—Dexamethasone—psoriatic arthritis	0.000221	0.00206	CcSEcCtD
Lidocaine—Sweating increased—Betamethasone—psoriatic arthritis	0.000221	0.00206	CcSEcCtD
Lidocaine—Haemoglobin—Prednisolone—psoriatic arthritis	0.000218	0.00204	CcSEcCtD
Lidocaine—Neuropathy peripheral—Triamcinolone—psoriatic arthritis	0.000218	0.00204	CcSEcCtD
Lidocaine—Neuropathy peripheral—Methylprednisolone—psoriatic arthritis	0.000218	0.00203	CcSEcCtD
Lidocaine—Haemorrhage—Prednisolone—psoriatic arthritis	0.000217	0.00203	CcSEcCtD
Lidocaine—Cardiac arrest—Prednisone—psoriatic arthritis	0.000217	0.00203	CcSEcCtD
Lidocaine—Visual impairment—Prednisolone—psoriatic arthritis	0.000209	0.00196	CcSEcCtD
Lidocaine—Bradycardia—Triamcinolone—psoriatic arthritis	0.000204	0.0019	CcSEcCtD
Lidocaine—Bradycardia—Methylprednisolone—psoriatic arthritis	0.000203	0.0019	CcSEcCtD
Lidocaine—Visual disturbance—Methotrexate—psoriatic arthritis	0.000201	0.00188	CcSEcCtD
Lidocaine—Haemoglobin—Triamcinolone—psoriatic arthritis	0.000201	0.00188	CcSEcCtD
Lidocaine—Haemoglobin—Methylprednisolone—psoriatic arthritis	0.0002	0.00187	CcSEcCtD
Lidocaine—Rhinitis—Triamcinolone—psoriatic arthritis	0.0002	0.00187	CcSEcCtD
Lidocaine—Rhinitis—Methylprednisolone—psoriatic arthritis	0.0002	0.00187	CcSEcCtD
Lidocaine—Haemorrhage—Triamcinolone—psoriatic arthritis	0.0002	0.00187	CcSEcCtD
Lidocaine—Haemorrhage—Methylprednisolone—psoriatic arthritis	0.000199	0.00186	CcSEcCtD
Lidocaine—Neuropathy peripheral—Dexamethasone—psoriatic arthritis	0.000198	0.00185	CcSEcCtD
Lidocaine—Neuropathy peripheral—Betamethasone—psoriatic arthritis	0.000198	0.00185	CcSEcCtD
Lidocaine—Anaphylactoid reaction—Methotrexate—psoriatic arthritis	0.000197	0.00184	CcSEcCtD
Lidocaine—Sweating increased—Prednisone—psoriatic arthritis	0.000192	0.00179	CcSEcCtD
Lidocaine—Visual impairment—Methylprednisolone—psoriatic arthritis	0.000192	0.00179	CcSEcCtD
Lidocaine—Osteoarthritis—Methotrexate—psoriatic arthritis	0.000191	0.00178	CcSEcCtD
Lidocaine—Erythema—Prednisolone—psoriatic arthritis	0.000189	0.00177	CcSEcCtD
Lidocaine—Eye disorder—Methylprednisolone—psoriatic arthritis	0.000186	0.00174	CcSEcCtD
Lidocaine—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.000185	0.00173	CcSEcCtD
Lidocaine—Bradycardia—Dexamethasone—psoriatic arthritis	0.000185	0.00172	CcSEcCtD
Lidocaine—Bradycardia—Betamethasone—psoriatic arthritis	0.000185	0.00172	CcSEcCtD
Lidocaine—Haemoglobin—Dexamethasone—psoriatic arthritis	0.000182	0.0017	CcSEcCtD
Lidocaine—Haemoglobin—Betamethasone—psoriatic arthritis	0.000182	0.0017	CcSEcCtD
Lidocaine—Haemorrhage—Dexamethasone—psoriatic arthritis	0.000181	0.00169	CcSEcCtD
Lidocaine—Haemorrhage—Betamethasone—psoriatic arthritis	0.000181	0.00169	CcSEcCtD
Lidocaine—Angiopathy—Methylprednisolone—psoriatic arthritis	0.000181	0.00169	CcSEcCtD
Lidocaine—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.00018	0.00168	CcSEcCtD
Lidocaine—Vision blurred—Prednisolone—psoriatic arthritis	0.000178	0.00166	CcSEcCtD
Lidocaine—Visual impairment—Betamethasone—psoriatic arthritis	0.000175	0.00163	CcSEcCtD
Lidocaine—Visual impairment—Dexamethasone—psoriatic arthritis	0.000175	0.00163	CcSEcCtD
Lidocaine—Erythema—Triamcinolone—psoriatic arthritis	0.000174	0.00162	CcSEcCtD
Lidocaine—Erythema—Methylprednisolone—psoriatic arthritis	0.000174	0.00162	CcSEcCtD
Lidocaine—Angioedema—Prednisolone—psoriatic arthritis	0.000173	0.00161	CcSEcCtD
Lidocaine—Neuropathy peripheral—Prednisone—psoriatic arthritis	0.000172	0.00161	CcSEcCtD
Lidocaine—Dysgeusia—Triamcinolone—psoriatic arthritis	0.00017	0.00159	CcSEcCtD
Lidocaine—Eye disorder—Dexamethasone—psoriatic arthritis	0.00017	0.00158	CcSEcCtD
Lidocaine—Eye disorder—Betamethasone—psoriatic arthritis	0.00017	0.00158	CcSEcCtD
Lidocaine—Back pain—Triamcinolone—psoriatic arthritis	0.000168	0.00157	CcSEcCtD
Lidocaine—Loss of consciousness—Prednisolone—psoriatic arthritis	0.000166	0.00155	CcSEcCtD
Lidocaine—Asthma—Methotrexate—psoriatic arthritis	0.000165	0.00154	CcSEcCtD
Lidocaine—Angiopathy—Dexamethasone—psoriatic arthritis	0.000165	0.00154	CcSEcCtD
Lidocaine—Angiopathy—Betamethasone—psoriatic arthritis	0.000165	0.00154	CcSEcCtD
Lidocaine—Convulsion—Prednisolone—psoriatic arthritis	0.000164	0.00153	CcSEcCtD
Lidocaine—Hypertension—Prednisolone—psoriatic arthritis	0.000163	0.00153	CcSEcCtD
Lidocaine—Bradycardia—Prednisone—psoriatic arthritis	0.000161	0.0015	CcSEcCtD
Lidocaine—Angioedema—Triamcinolone—psoriatic arthritis	0.000159	0.00148	CcSEcCtD
Lidocaine—Haemoglobin—Prednisone—psoriatic arthritis	0.000159	0.00148	CcSEcCtD
Lidocaine—Angioedema—Methylprednisolone—psoriatic arthritis	0.000159	0.00148	CcSEcCtD
Lidocaine—Haemorrhage—Prednisone—psoriatic arthritis	0.000158	0.00147	CcSEcCtD
Lidocaine—Erythema—Dexamethasone—psoriatic arthritis	0.000158	0.00147	CcSEcCtD
Lidocaine—Erythema—Betamethasone—psoriatic arthritis	0.000158	0.00147	CcSEcCtD
Lidocaine—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.000154	0.00144	CcSEcCtD
Lidocaine—Oedema—Prednisolone—psoriatic arthritis	0.000154	0.00144	CcSEcCtD
Lidocaine—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.000153	0.00143	CcSEcCtD
Lidocaine—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.000153	0.00142	CcSEcCtD
Lidocaine—Shock—Prednisolone—psoriatic arthritis	0.000152	0.00142	CcSEcCtD
Lidocaine—Convulsion—Triamcinolone—psoriatic arthritis	0.000151	0.00141	CcSEcCtD
Lidocaine—Convulsion—Methylprednisolone—psoriatic arthritis	0.00015	0.0014	CcSEcCtD
Lidocaine—Hypertension—Triamcinolone—psoriatic arthritis	0.00015	0.0014	CcSEcCtD
Lidocaine—Hypertension—Methylprednisolone—psoriatic arthritis	0.00015	0.0014	CcSEcCtD
Lidocaine—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000149	0.00139	CcSEcCtD
Lidocaine—Eye disorder—Prednisone—psoriatic arthritis	0.000148	0.00138	CcSEcCtD
Lidocaine—Anxiety—Methylprednisolone—psoriatic arthritis	0.000147	0.00138	CcSEcCtD
Lidocaine—Drowsiness—Methotrexate—psoriatic arthritis	0.000147	0.00137	CcSEcCtD
Lidocaine—Flushing—Prednisone—psoriatic arthritis	0.000147	0.00137	CcSEcCtD
Lidocaine—Angioedema—Dexamethasone—psoriatic arthritis	0.000144	0.00135	CcSEcCtD
Lidocaine—Angioedema—Betamethasone—psoriatic arthritis	0.000144	0.00135	CcSEcCtD
Lidocaine—Stomatitis—Methotrexate—psoriatic arthritis	0.000143	0.00134	CcSEcCtD
Lidocaine—Angiopathy—Prednisone—psoriatic arthritis	0.000143	0.00134	CcSEcCtD
Lidocaine—Confusional state—Methylprednisolone—psoriatic arthritis	0.000143	0.00133	CcSEcCtD
Lidocaine—Immune system disorder—Prednisone—psoriatic arthritis	0.000143	0.00133	CcSEcCtD
Lidocaine—Oedema—Triamcinolone—psoriatic arthritis	0.000142	0.00133	CcSEcCtD
Lidocaine—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000142	0.00133	CcSEcCtD
Lidocaine—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000142	0.00132	CcSEcCtD
Lidocaine—Shock—Triamcinolone—psoriatic arthritis	0.00014	0.0013	CcSEcCtD
Lidocaine—Shock—Methylprednisolone—psoriatic arthritis	0.000139	0.0013	CcSEcCtD
Lidocaine—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000139	0.0013	CcSEcCtD
Lidocaine—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000139	0.0013	CcSEcCtD
Lidocaine—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000139	0.0013	CcSEcCtD
Lidocaine—Paraesthesia—Prednisolone—psoriatic arthritis	0.000139	0.00129	CcSEcCtD
Lidocaine—Erythema—Prednisone—psoriatic arthritis	0.000138	0.00128	CcSEcCtD
Lidocaine—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000137	0.00128	CcSEcCtD
Lidocaine—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000137	0.00128	CcSEcCtD
Lidocaine—Convulsion—Betamethasone—psoriatic arthritis	0.000137	0.00128	CcSEcCtD
Lidocaine—Convulsion—Dexamethasone—psoriatic arthritis	0.000137	0.00128	CcSEcCtD
Lidocaine—Hypertension—Dexamethasone—psoriatic arthritis	0.000136	0.00127	CcSEcCtD
Lidocaine—Hypertension—Betamethasone—psoriatic arthritis	0.000136	0.00127	CcSEcCtD
Lidocaine—Anxiety—Dexamethasone—psoriatic arthritis	0.000134	0.00125	CcSEcCtD
Lidocaine—Anxiety—Betamethasone—psoriatic arthritis	0.000134	0.00125	CcSEcCtD
Lidocaine—Haemoglobin—Methotrexate—psoriatic arthritis	0.000133	0.00124	CcSEcCtD
Lidocaine—Hypotension—Methylprednisolone—psoriatic arthritis	0.000132	0.00124	CcSEcCtD
Lidocaine—Pain—Prednisolone—psoriatic arthritis	0.000132	0.00123	CcSEcCtD
Lidocaine—Haemorrhage—Methotrexate—psoriatic arthritis	0.000132	0.00123	CcSEcCtD
Lidocaine—Vision blurred—Prednisone—psoriatic arthritis	0.00013	0.00121	CcSEcCtD
Lidocaine—Oedema—Betamethasone—psoriatic arthritis	0.000129	0.0012	CcSEcCtD
Lidocaine—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000129	0.0012	CcSEcCtD
Lidocaine—Oedema—Dexamethasone—psoriatic arthritis	0.000129	0.0012	CcSEcCtD
Lidocaine—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000129	0.0012	CcSEcCtD
Lidocaine—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000128	0.00119	CcSEcCtD
Lidocaine—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000127	0.00119	CcSEcCtD
Lidocaine—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000127	0.00119	CcSEcCtD
Lidocaine—Visual impairment—Methotrexate—psoriatic arthritis	0.000127	0.00119	CcSEcCtD
Lidocaine—Shock—Dexamethasone—psoriatic arthritis	0.000127	0.00118	CcSEcCtD
Lidocaine—Shock—Betamethasone—psoriatic arthritis	0.000127	0.00118	CcSEcCtD
Lidocaine—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000127	0.00118	CcSEcCtD
Lidocaine—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000126	0.00118	CcSEcCtD
Lidocaine—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000126	0.00118	CcSEcCtD
Lidocaine—Agitation—Prednisone—psoriatic arthritis	0.000126	0.00118	CcSEcCtD
Lidocaine—Angioedema—Prednisone—psoriatic arthritis	0.000126	0.00117	CcSEcCtD
Lidocaine—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000125	0.00116	CcSEcCtD
Lidocaine—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000125	0.00116	CcSEcCtD
Lidocaine—Eye disorder—Methotrexate—psoriatic arthritis	0.000123	0.00115	CcSEcCtD
Lidocaine—Tinnitus—Methotrexate—psoriatic arthritis	0.000123	0.00115	CcSEcCtD
Lidocaine—Urticaria—Prednisolone—psoriatic arthritis	0.000123	0.00115	CcSEcCtD
Lidocaine—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000123	0.00114	CcSEcCtD
Lidocaine—Pain—Triamcinolone—psoriatic arthritis	0.000121	0.00113	CcSEcCtD
Lidocaine—Loss of consciousness—Prednisone—psoriatic arthritis	0.000121	0.00113	CcSEcCtD
Lidocaine—Hypotension—Betamethasone—psoriatic arthritis	0.00012	0.00112	CcSEcCtD
Lidocaine—Hypotension—Dexamethasone—psoriatic arthritis	0.00012	0.00112	CcSEcCtD
Lidocaine—Angiopathy—Methotrexate—psoriatic arthritis	0.00012	0.00112	CcSEcCtD
Lidocaine—Immune system disorder—Methotrexate—psoriatic arthritis	0.000119	0.00111	CcSEcCtD
Lidocaine—Convulsion—Prednisone—psoriatic arthritis	0.000119	0.00111	CcSEcCtD
Lidocaine—Hypertension—Prednisone—psoriatic arthritis	0.000119	0.00111	CcSEcCtD
Lidocaine—Chills—Methotrexate—psoriatic arthritis	0.000118	0.00111	CcSEcCtD
Lidocaine—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000117	0.00109	CcSEcCtD
Lidocaine—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000117	0.00109	CcSEcCtD
Lidocaine—Anxiety—Prednisone—psoriatic arthritis	0.000117	0.00109	CcSEcCtD
Lidocaine—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000116	0.00108	CcSEcCtD
Lidocaine—Paraesthesia—Betamethasone—psoriatic arthritis	0.000116	0.00108	CcSEcCtD
Lidocaine—Erythema—Methotrexate—psoriatic arthritis	0.000115	0.00107	CcSEcCtD
Lidocaine—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000114	0.00106	CcSEcCtD
Lidocaine—Urticaria—Triamcinolone—psoriatic arthritis	0.000113	0.00105	CcSEcCtD
Lidocaine—Urticaria—Methylprednisolone—psoriatic arthritis	0.000113	0.00105	CcSEcCtD
Lidocaine—Dysgeusia—Methotrexate—psoriatic arthritis	0.000113	0.00105	CcSEcCtD
Lidocaine—Oedema—Prednisone—psoriatic arthritis	0.000112	0.00105	CcSEcCtD
Lidocaine—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000112	0.00105	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000111	0.00104	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000111	0.00104	CcSEcCtD
Lidocaine—Back pain—Methotrexate—psoriatic arthritis	0.000111	0.00104	CcSEcCtD
Lidocaine—Shock—Prednisone—psoriatic arthritis	0.00011	0.00103	CcSEcCtD
Lidocaine—Pain—Betamethasone—psoriatic arthritis	0.00011	0.00103	CcSEcCtD
Lidocaine—Pain—Dexamethasone—psoriatic arthritis	0.00011	0.00103	CcSEcCtD
Lidocaine—Nervous system disorder—Prednisone—psoriatic arthritis	0.00011	0.00103	CcSEcCtD
Lidocaine—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000108	0.00101	CcSEcCtD
Lidocaine—Vision blurred—Methotrexate—psoriatic arthritis	0.000108	0.00101	CcSEcCtD
Lidocaine—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000106	0.000991	CcSEcCtD
Lidocaine—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000106	0.000991	CcSEcCtD
Lidocaine—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000105	0.000977	CcSEcCtD
Lidocaine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000104	0.000975	CcSEcCtD
Lidocaine—Urticaria—Betamethasone—psoriatic arthritis	0.000102	0.000956	CcSEcCtD
Lidocaine—Urticaria—Dexamethasone—psoriatic arthritis	0.000102	0.000956	CcSEcCtD
Lidocaine—Dizziness—Prednisolone—psoriatic arthritis	0.000102	0.000953	CcSEcCtD
Lidocaine—Asthenia—Triamcinolone—psoriatic arthritis	0.000102	0.000951	CcSEcCtD
Lidocaine—Asthenia—Methylprednisolone—psoriatic arthritis	0.000102	0.000949	CcSEcCtD
Lidocaine—Paraesthesia—Prednisone—psoriatic arthritis	0.000101	0.000941	CcSEcCtD
Lidocaine—Convulsion—Methotrexate—psoriatic arthritis	9.96e-05	0.000929	CcSEcCtD
Lidocaine—Chest pain—Methotrexate—psoriatic arthritis	9.78e-05	0.000913	CcSEcCtD
Lidocaine—Rash—Prednisolone—psoriatic arthritis	9.74e-05	0.000909	CcSEcCtD
Lidocaine—Dermatitis—Prednisolone—psoriatic arthritis	9.73e-05	0.000908	CcSEcCtD
Lidocaine—Headache—Prednisolone—psoriatic arthritis	9.68e-05	0.000903	CcSEcCtD
Lidocaine—Confusional state—Methotrexate—psoriatic arthritis	9.46e-05	0.000883	CcSEcCtD
Lidocaine—Dizziness—Triamcinolone—psoriatic arthritis	9.39e-05	0.000877	CcSEcCtD
Lidocaine—Anaphylactic shock—Methotrexate—psoriatic arthritis	9.38e-05	0.000875	CcSEcCtD
Lidocaine—Dizziness—Methylprednisolone—psoriatic arthritis	9.37e-05	0.000875	CcSEcCtD
Lidocaine—Feeling abnormal—Prednisone—psoriatic arthritis	9.25e-05	0.000863	CcSEcCtD
Lidocaine—Asthenia—Dexamethasone—psoriatic arthritis	9.25e-05	0.000863	CcSEcCtD
Lidocaine—Asthenia—Betamethasone—psoriatic arthritis	9.25e-05	0.000863	CcSEcCtD
Lidocaine—Nervous system disorder—Methotrexate—psoriatic arthritis	9.2e-05	0.000859	CcSEcCtD
Lidocaine—Nausea—Prednisolone—psoriatic arthritis	9.17e-05	0.000856	CcSEcCtD
Lidocaine—Hyperhidrosis—Methotrexate—psoriatic arthritis	9.07e-05	0.000846	CcSEcCtD
Lidocaine—Vomiting—Triamcinolone—psoriatic arthritis	9.03e-05	0.000843	CcSEcCtD
Lidocaine—Vomiting—Methylprednisolone—psoriatic arthritis	9.01e-05	0.000841	CcSEcCtD
Lidocaine—Rash—Triamcinolone—psoriatic arthritis	8.96e-05	0.000836	CcSEcCtD
Lidocaine—Dermatitis—Triamcinolone—psoriatic arthritis	8.95e-05	0.000835	CcSEcCtD
Lidocaine—Rash—Methylprednisolone—psoriatic arthritis	8.94e-05	0.000834	CcSEcCtD
Lidocaine—Dermatitis—Methylprednisolone—psoriatic arthritis	8.93e-05	0.000833	CcSEcCtD
Lidocaine—Urticaria—Prednisone—psoriatic arthritis	8.92e-05	0.000832	CcSEcCtD
Lidocaine—Headache—Triamcinolone—psoriatic arthritis	8.9e-05	0.000831	CcSEcCtD
Lidocaine—Headache—Methylprednisolone—psoriatic arthritis	8.88e-05	0.000829	CcSEcCtD
Lidocaine—Hypotension—Methotrexate—psoriatic arthritis	8.76e-05	0.000818	CcSEcCtD
Lidocaine—Dizziness—Betamethasone—psoriatic arthritis	8.52e-05	0.000795	CcSEcCtD
Lidocaine—Dizziness—Dexamethasone—psoriatic arthritis	8.52e-05	0.000795	CcSEcCtD
Lidocaine—Nausea—Triamcinolone—psoriatic arthritis	8.44e-05	0.000787	CcSEcCtD
Lidocaine—Paraesthesia—Methotrexate—psoriatic arthritis	8.42e-05	0.000786	CcSEcCtD
Lidocaine—Nausea—Methylprednisolone—psoriatic arthritis	8.42e-05	0.000786	CcSEcCtD
Lidocaine—Dyspnoea—Methotrexate—psoriatic arthritis	8.36e-05	0.000781	CcSEcCtD
Lidocaine—Somnolence—Methotrexate—psoriatic arthritis	8.34e-05	0.000778	CcSEcCtD
Lidocaine—Hypersensitivity—Prednisone—psoriatic arthritis	8.27e-05	0.000772	CcSEcCtD
Lidocaine—Vomiting—Betamethasone—psoriatic arthritis	8.19e-05	0.000765	CcSEcCtD
Lidocaine—Vomiting—Dexamethasone—psoriatic arthritis	8.19e-05	0.000765	CcSEcCtD
Lidocaine—Rash—Dexamethasone—psoriatic arthritis	8.13e-05	0.000758	CcSEcCtD
Lidocaine—Rash—Betamethasone—psoriatic arthritis	8.13e-05	0.000758	CcSEcCtD
Lidocaine—Dermatitis—Betamethasone—psoriatic arthritis	8.12e-05	0.000758	CcSEcCtD
Lidocaine—Dermatitis—Dexamethasone—psoriatic arthritis	8.12e-05	0.000758	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	8.1e-05	0.000756	CcSEcCtD
Lidocaine—Headache—Dexamethasone—psoriatic arthritis	8.07e-05	0.000754	CcSEcCtD
Lidocaine—Headache—Betamethasone—psoriatic arthritis	8.07e-05	0.000754	CcSEcCtD
Lidocaine—Asthenia—Prednisone—psoriatic arthritis	8.05e-05	0.000752	CcSEcCtD
Lidocaine—Pain—Methotrexate—psoriatic arthritis	8.02e-05	0.000749	CcSEcCtD
Lidocaine—Feeling abnormal—Methotrexate—psoriatic arthritis	7.73e-05	0.000721	CcSEcCtD
Lidocaine—Nausea—Dexamethasone—psoriatic arthritis	7.65e-05	0.000714	CcSEcCtD
Lidocaine—Nausea—Betamethasone—psoriatic arthritis	7.65e-05	0.000714	CcSEcCtD
Lidocaine—Urticaria—Methotrexate—psoriatic arthritis	7.45e-05	0.000695	CcSEcCtD
Lidocaine—Dizziness—Prednisone—psoriatic arthritis	7.42e-05	0.000693	CcSEcCtD
Lidocaine—Vomiting—Prednisone—psoriatic arthritis	7.14e-05	0.000666	CcSEcCtD
Lidocaine—Rash—Prednisone—psoriatic arthritis	7.08e-05	0.00066	CcSEcCtD
Lidocaine—Dermatitis—Prednisone—psoriatic arthritis	7.07e-05	0.00066	CcSEcCtD
Lidocaine—Headache—Prednisone—psoriatic arthritis	7.03e-05	0.000656	CcSEcCtD
Lidocaine—Hypersensitivity—Methotrexate—psoriatic arthritis	6.91e-05	0.000645	CcSEcCtD
Lidocaine—Asthenia—Methotrexate—psoriatic arthritis	6.73e-05	0.000628	CcSEcCtD
Lidocaine—Nausea—Prednisone—psoriatic arthritis	6.67e-05	0.000622	CcSEcCtD
Lidocaine—Dizziness—Methotrexate—psoriatic arthritis	6.2e-05	0.000579	CcSEcCtD
Lidocaine—Vomiting—Methotrexate—psoriatic arthritis	5.96e-05	0.000557	CcSEcCtD
Lidocaine—Rash—Methotrexate—psoriatic arthritis	5.91e-05	0.000552	CcSEcCtD
Lidocaine—Dermatitis—Methotrexate—psoriatic arthritis	5.91e-05	0.000551	CcSEcCtD
Lidocaine—Headache—Methotrexate—psoriatic arthritis	5.88e-05	0.000548	CcSEcCtD
Lidocaine—Nausea—Methotrexate—psoriatic arthritis	5.57e-05	0.00052	CcSEcCtD
